- Home
- Products
- Customized FluoroAb™
- SAIL
- Anti-SAIL MAb (Clone 1)-iFluor® 430 Succinimidyl Ester
Anti-SAIL MAb (Clone 1)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3597)
This product is comprised of an Anti-SAIL Antibody (Clone 1) labeled with iFluor® 430 Succinimidyl Ester. iFluor® 430 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- SAIL
- Overview
- Anti-SAIL Antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 430 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 433/498
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-EDA MAb (Clone 6)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4065)
- Anti-IL17A MAb (Clone 10)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2855)
- Vantictumab-iFluor 594 (CAT#: ADC-FL-1574)
- Anti-MET MAb (Clone 18)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13715)
- Anti-EphA2 MAb (Clone 2)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8116)
- Anti-LYPD3 MAb (Clone 3)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9756)
- Crenezumab-Bodipy FL (CAT#: ADC-FL-120)
- Anti-VEGFA MAb (Clone 6)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9235)
- Anti-TFPI MAb (Clone 3)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4575)
- Anti-ITGA2 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS644)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS3597. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-552 | Anti-SAIL-Mc-MMAF ADC-2 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-553 | Anti-SAIL-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.